GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Lab] 6th independent test on SWB — 99.1% on a claimed 99.0%, and the trend is the interesting part — 29 comments in the full submission. View in context.
507
c/orforglipron·submitted 2 years ago by u/preservative_free_p

[Lab] 6th independent test on SWB — 99.1% on a claimed 99.0%, and the trend is the interesting part

Speculationbranch of 10 comments

Short version of the title, which is already short: 6th independent test on SWB — 99.1% on a claimed 99.0%, and the trend is the interesting part. Longer version underneath. To save the first four comments: 99.1% and 99.0%. Daily rather than weekly sounds trivial until you think about what a missed dose means in each…

Read the full submission and all 29 comments →

This branch

10 comments, started 2 years ago
u/incretin_ivypharmacology18 points·2 years ago

Why "oral" is doing two completely different jobs in the sentences people write here.

Oral semaglutide is a peptide co-formulated with an absorption enhancer, which is why it comes with food and water timing requirements. This compound is a non-peptide small molecule that activates the same receptor, formulated as an ordinary tablet.

The practical consequences differ enormously: no timing constraints, a conventional manufacturing route, different stability behaviour, and a different analytical problem for anybody trying to verify identity or purity. Whenever a thread here compares the two, check which sense of "oral" each half is using.

replysharereportpermalink
u/preservative_free_pOP9 points·2 years ago

Which programme and which readout are you quoting?

replysharereportpermalink
u/anders_karlsen7 points·2 years ago

a non-peptide agonist does not degrade the way a peptide does

replysharereportpermalink
u/jonas_cardoso13 points·2 years ago

the tolerability profile reads broadly similar to the class

replysharereportpermalink
u/fatima_kowalski3 points·2 years ago

daily dosing, not weekly, so the exposure profile is different

replysharereportpermalink
u/preservative_free_pOP2 points·2 years ago

daily dosing changes adherence in both directions

replysharereportpermalink
u/trialwatch_theoMOD12 points·2 years ago

Retitled to name the programme. It is what makes these threads findable in a year.

replysharereportpermalink
u/laila_delgado10 points·2 years ago

Read both programme names carefully after mixing them up in a comment and being politely corrected.

replysharereportpermalink
u/dario_boateng13 points·2 years ago

Daily dosing gives a very different exposure profile from a weekly injectable: peaks and troughs within each day rather than a smoothed weekly curve.

replysharereportpermalink
u/bruno_dumitru8 points·2 years ago·edited

Small fix — the two programme names got swapped upthread and it changes which population the figure came from.

replysharereportpermalink

← back to the whole thread

About c/orforglipron

The small-molecule oral: why a non-peptide agonist escapes the absorption problems of oral semaglutide, what the ATTAIN and ACHIEVE readouts showed, and what a pill with no refrigeration requirement would do to the entire supply conversation this site is built around.

21kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/orforglipron rules
  1. Small molecule, not a peptide. Purity discussion here is a different problem.
  2. Cite ATTAIN/ACHIEVE arms specifically when quoting numbers.
  3. Availability speculation must be flaired Speculation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.